Advanced search
Start date
Betweenand


Alpha 1-acid glycoprotein is upregulated in severe COVID-19 patients and decreases neutrophil NETs in SARS-CoV-2 infection

Full text
Author(s):
Show less -
Mestriner, Fabiola ; Francisco, Daniely F. ; Campos, Ligia C. B. ; Couto, Ariel E. S. ; Fraga-Silva, Thais F. C. ; Dugaich, Vinicius Flora ; Avila-Mesquita, Carolina D. ; Kovacs, Henrique Zukowski ; Vasconcelos, Jociany L. ; Milani, Elizabete R. ; de Sa, Keyla Santos Guedes ; Martins, Ronaldo ; Jordani, Maria C. ; Corsi, Carlos A. C. ; Barbosa, Jessyca M. ; Vasconcelos, Tauana ; Menegueti, Mayra Goncalves ; Neto, Julio ; da Costa, Rafael M. ; Evora, Paulo R. B. ; Arruda, Eurico ; Tostes, Rita ; Polonis, Katarzyna ; Bonato, Vania L. D. ; Auxiliadora-Martins, Maria ; Ribeiro, Mauricio S. ; Becari, Christiane
Total Authors: 27
Document type: Journal article
Source: CYTOKINE; v. 176, p. 12-pg., 2024-01-31.
Abstract

Orosomucoid, or alpha-1 acid glycoprotein (AGP), is a major acute-phase protein expressed in response to systemic injury and inflammation. AGP has been described as an inhibitor of neutrophil migration on sepsis, particularly its immunomodulation effects. AGP's biological functions in coronavirus disease 2019 (COVID-19) are not understood. We sought to investigate the role of AGP in severe COVID-19 infection patients and neutrophils infected with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Epidemiological data, AGP levels, and other laboratory parameters were measured in blood samples from 56 subjects hospitalized in the ICU with SARS-CoV-2 infection. To evaluate the role of AGP in NETosis in neutrophils, blood samples from health patients were collected, and neutrophils were separated and infected with SARS-CoV-2. Those neutrophils were treated with AGP or vehicle, and NETosis was analyzed by flow cytometry. AGP was upregulated in severe COVID-19 patients (p<0.05). AGP level was positively correlated with IL-6 and C-reactive protein (respectively, p=0.005, p=0.002) and negatively correlated with lactate (p=0.004). AGP treatment downregulated early and late NETosis (respectively, 35.7% and 43.5%) in neutrophils infected with SARS-CoV-2 and up-regulated IL-6 supernatant culture expression (p<0.0001). Our data showed increased AGP in COVID-19 infection and contributed to NETosis regulation and increased IL-6 production, possibly related to the Cytokine storm in COVID-19. (AU)

FAPESP's process: 19/21721-4 - Biochemical and molecular analysis of the renin-angiotensin system (RAS) components in the pathophysiology of abdominal aortic aneurysm (AAA) in patients undergoing AAA correction surgery at HCRP-USP
Grantee:Jéssyca Michelon Barbosa
Support Opportunities: Scholarships in Brazil - Master
FAPESP's process: 23/14949-4 - Effects of Dapagliflozin treatment on the progression of Abdominal Aortic Aneurysm in an experimental model of mice subjected to chronic infusion of angiotensin II
Grantee:Henrique Zukowski Kovacs
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 20/03308-0 - Aorta morphological analysis of ELA-2KO mice with abdominal aortic aneurysm induced by the infusion of Angiotensin II
Grantee:Ariel Emiliano Souza do Couto
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 18/23718-8 - Role of renin angiotensin system in abdominal aortic aneurysm
Grantee:Christiane Becari
Support Opportunities: Scholarships in Brazil - Young Researchers
FAPESP's process: 18/26553-0 - A randomized, placebo-controlled study evaluating the hemodynamic and metabolic effects of Methylene blue treatment in septic shock
Grantee:Maria Auxiliadora Martins
Support Opportunities: Regular Research Grants
FAPESP's process: 23/08275-0 - Plasmatic and tissue assessment of inflammatory mediators, angiotensin I and II receptors, renin, angiotensin-converting enzymes, chymase and elastase-2 in patients with and without abdominal aortic aneurysm submitted to surgery at HCRP-USP
Grantee:Vinicius Flora Dugaich
Support Opportunities: Scholarships in Brazil - Doctorate (Direct)
FAPESP's process: 20/05691-5 - Evaluation of pro-thrombotic markers in plasma obtained from patients submitted to the varice techniques' treatment in the public health system
Grantee:Fabiola Leslie Antunes Cardoso Mestriner
Support Opportunities: Scholarships in Brazil - Technical Training Program - Technical Training
FAPESP's process: 19/24369-0 - Renin-angiotensin system molecular analyses an in the development of in the Ang-II induced aneurysm in mice
Grantee:Carolina D'Avila Mesquita
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 19/11485-1 - Evaluation of cost-effectiveness and thrombotic markers of the varice techniques' treatment in the public health system
Grantee:Mauricio Serra Ribeiro
Support Opportunities: Regular Research Grants
FAPESP's process: 22/13048-0 - Angiotensin generation profile in the aorta of mice and patients with abdominal aortic aneurysm (AAA)
Grantee:Daniely Franco Francisco
Support Opportunities: Scholarships in Brazil - Scientific Initiation
FAPESP's process: 21/08796-5 - CharacterizationElastase-2 knockout mice growth, mating, and genotyping analysis.
Grantee:Jociany Lopes de Vasconcelos
Support Opportunities: Scholarships in Brazil - Technical Training Program - Technical Training
FAPESP's process: 20/09999-4 - Biochemical characterization of angiotensin (Ang) I without plasma and aorta of C57Bl / 6 and ELA-2KO mice with abdominal aortic aneurysm (AAA) induced by the infusion of II
Grantee:Lígia Cristina Borges Campos
Support Opportunities: Scholarships in Brazil - Scientific Initiation